Pharmacy Times OTC Recommendations Survey: Why It Matters

Published Online: Sunday, June 1, 2008

Every month, pharmacists make millions of recommendations from among the 1000+ OTC brands. The 2008 Pharmacy Times OTC Recommendations Survey asked thousands of pharmacists to declare their preferred recommendations on brands in 142 OTC categories. In the tables that follow, products are organized by category with the percentage of pharmacists' recommendations that they received. The tables also show the total number of recommendations the retail pharmacy profession makes each month.

OTC Pharmacy Times Master's Circle seal - Pharmacist Recommended 2008 Achievement AwardsThe Pharmacy Times OTC Master's Circle is an elite club made up of those products from the OTC Recommendation Survey that earned at least 50% of pharmacists' recommendations. The OTC Master's Circle features 43 products this year.

OTC Pharmacy Times seal - Pharmacist Recommended 2008 Achievement AwardsScoring well in the Pharmacy Times OTC Recommendations Survey matters. Our readers thoughtfully consider the recommendations of their peers?"Is that what I recommend?" "Should that be what I recommend?" And with billion-dollar blockbuster prescription drugs switching to OTC status, pharmacists will be called on to guide patient choices like never before.

Product manufacturers are also very interested to see what products are at the top of their respective categories. Winners in the 2008 Pharmacy Times OTC Recommendations Survey?those products that received the highest percentage of pharmacist recommendations in their category?qualify to use the Pharmacy Times Achievement Award logo. And Master's Circle winners?those that received 50% or more of all pharmacist recommendations in the category?qualify to use the OTC Master's Circle Achievement Award logo. Winning brand managers are proud of this achievement, and these logos are frequently included in product advertising throughout the year.

Pharmacy Times is pleased to present this year's OTC recommendations.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues